Biosimilars

The Pharmacy Times® Biosimilars Resource Center is a comprehensive resource for clinical news and expert insights on issues related to biosimilar drugs, a biological product that is highly similar to a reference biologic for which there are no clinically meaningful differences in terms of safety, purity, and efficacy.

Latest News

US Capitol Building Dome at dusk | Image Credit: doganmesut - stock.adobe.com
NCPA, Biosimilar Forum Voice Support for PBM Reform Bill

March 18th 2024

Senators Ron Wyden and Mike Crapo reaffirm their support on 2 health care bills that passed the United States Senate Committee on Finance in 2023.

New Tool Helps Providers Navigate Adalimumab Biosimilars
New Tool Helps Providers Navigate Adalimumab Biosimilars

March 14th 2024

a man holds a hand at a psoriasis affected area of the skin | Image Credit SergeVo - stock.adobe.com
Study: SB17 Shows Biosimilarity to Ustekinumab for Plaque Psoriasis

March 8th 2024

biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Report: 2024 Projected to Be A Big Year for Biosimilars in the Retina Space

March 8th 2024

Medical concept of FDA approved. Food and drugs administration quality control. | Image Credit: wladimir1804 - stock.adobe.com
FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications

March 7th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.